Islas-Flores, Hariz;Perez-Alvarez, Itzayana;Gomez-Olivan, Leobardo M. published 《Evaluation of teratogenicity of pharmaceuticals using FETAX》 in 2018. The article was appeared in 《Methods in Molecular Biology (New York, NY, United States)》. They have made some progress in their research.Reference of 6-Aminonicotinamide The article mentions the following:
A review. Pharmaceuticals are chem.compounds which are used to preserve human and animal health. Once administered, these compoundsare metabolized or can remain unaltered until excreted. Therefore, a mixtureof pharmaceuticals and their metabolites enters municipal sewers and wastewater treatment plants where, depending on their polarity, water solubility, and persistence, they cannot be completely removed or transformed during the treatment process, so that unaltered pharmaceuticals and/or their metabolites can enter surface water. As a result, in recent years concern has grown about trace concentrations and the risk they pose to ecosystems, considering the annual increase in pharmaceutical productionand use at world level. This chapter reviews the frog embryo teratogenesis assay-Xenopus (FETAX). Originally developed during the mid-1980s as a test for detecting the developmental toxicity of pure chem. products and complex mixturesin the laboratory, in recent years it has been used to evaluate the mechanisms of action, biotransformation, and detoxification of xenobiotics as well as in ecotoxicol. studies using alternative species and in situ monitoring. And 6-Aminonicotinamide (cas: 329-89-5) was used in the research process.
6-Aminonicotinamide (cas:329-89-5)Reference of 6-Aminonicotinamide is a well-established inhibitor of the NADP+-dependent enzyme, 6-phosphogluconate dehydrogenase (Ki = 0.46 μM). 6-Aminonicotinamide also reduces cardiovascular oxidative injury following ischemia/reperfusion.
Reference:
Amide – Wikipedia,
Amide – an overview | ScienceDirect Topics